Tag : Israel

CCT Impact

IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel

CCT IMPACT Agent
IM Cannabis Corp. (the “Company” or “IM Cannabis“) (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has completed three strategic acquisitions announced in 2021. The acquisitions were completed through IMC Holdings Ltd. (“IMC Holdings“), a wholly-owned subsidiary of IM Cannabis Corp. and I.M.C Pharma......
CCT Impact

Cantourage brings first Ugandan medical cannabis to Germany through partnership with Israel’s Together Pharma

CCT IMPACT Agent
European medical cannabis leader Cantourage and Israeli medical cannabis producer Together Pharma (TASE: TGTR) have formed a partnership that will see the first Ugandan medical cannabis brought to Germany. From today, pharmacies and patients throughout Germany will have access to two of Together Pharma’s THC genetics: Glueberry OG® and Power Plant. The dried flower......
CCT Impact

Canonic Announces Full Commercial Launch of its First Medical Cannabis Products in Israel

CCT IMPACT Agent
Canonic Ltd., focused on the development of medical cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced the full commercial launch of its first two medical cannabis products, known as G200 and G150, following positive feedback received from patients during the company’s pre-launch campaign. These......
CCT Impact

Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel

CCT IMPACT Agent
Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the pre-launch of its first-generation medical cannabis inflorescence products. Evogene Logo (PRNewsfoto/Evogene) G-nnovation first products G-nnovation first products Canonic’s first product line, G-nnovation, is based on......
CCT Impact

Cannassure was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority

CCT IMPACT Agent
Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority. The company’s innovative technology enables the provision of an exact amount of active ingredients......
CCT Impact

Panaxia Israel announces estimated record revenues of at least 19 million in Q1 2021

CCT IMPACT Agent
The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (“Panaxia Israel”) (TASE: PNAX), Israel’s largest manufacturer of medical cannabis products, today announced its estimated revenues for the first quarter of 2021. According to Panaxia’s estimates, its consolidated (unaudited) revenues for the first quarter of 2021 are expected to reach no less than 19 million.......
CCT Impact

Subversive Acquisition LP Provides Update on Qualifying Transaction with Intercure, Israel’s Leading and Fastest-Growing Cannabis Company

CCT IMPACT Agent
SUBVERSIVE ACQUISITION LP (TSX: SVX.U) (NEO: SVX.U) (OTCQX: SBVRF) (“SVX“) provided an update today on its qualifying transaction to combine with InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure“), Israel’s leading cannabis company (the “Qualifying Transaction“). 1. Closing SVX currently expects the Qualifying Transaction to close (the “Closing“) on April 8, 2021. 2. Meeting SVX will hold a special......
CCT Impact

Canonic Received Approval for Propagation of Medical Cannabis from the Israel Medical Cannabis Agency

CCT IMPACT Agent
Canonic, a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN) focused on the development of medical cannabis products, announces today receiving an IMC-GAP approval from the Israel Medical Cannabis Agency for the commercial operation of its propagation farm. This approval will allow Canonic to proceed with the execution of......
Market Watch

Panaxia Global Reports: Panaxia Israel Continues to Grow

CCT IMPACT Agent
The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (Panaxia Israel) (TASE: PNAX), the largest manufacturer of medical cannabis products in Israel, today reported the financial results for the second quarter and first half of 2020. Quarterly revenues, 2018-2020, in millions Dr. Dadi Segal, CEO of Panaxia Global, said, “The past six months have been......
Politics

Trump Could Use U.S. Trade Agreements to Bully Canada’s Emerging Cannabis Industry

Editor
Last month, (allegedly) following a call from U.S. President Donald Trump, Israeli Prime Minister Benjamin Netanyahu delayed a long-held plan to export Israeli medicinal cannabis. It was a troubling moment for Canada’s cannabis sector, as it signaled the possibility that he could try a similar direct or indirect tactic to......